Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nissin Sugar is a prominent Japanese sugar refiner that has significantly expanded into the life sciences and wellness sectors through the development of functional carbohydrates. Following its merger with Mitsui Sugar to form Mitsui DM Sugar Holdings, the company continues to produce high-purity sugar products alongside specialized ingredients like Palatinose (isomaltulose) and cyclodextrins. These functional ingredients are utilized in the pharmaceutical industry as advanced excipients for drug delivery and in the nutraceutical industry for metabolic health management. The company's research focuses on the physiological benefits of sugars, including slow-release energy and glycemic control. Nissin Sugar operates multiple manufacturing facilities and R&D centers dedicated to innovating carbohydrate-based solutions for healthcare and food applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nissin Sugar.